Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Lu Hongbo
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
- Servier Presentations at ISPNO 2026 Highlight Neuro-Oncology Leadership and Expanding Glioma Portfolio
- Semrush Releases Expanded 2026 AI Visibility Index, Analyzing 126 Million AI Search Prompts
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
